Twelve-month outcomes in patients with diabetes implanted with a zotarolimus-eluting stent: results from the E-Five Registry

Ajay Jain, Chaim Lotan, Ian Meredith, Faustos Feres, Robaayah Zambahari, Nakul Sinha, Martin Rothman

Research output: Contribution to journalArticleResearchpeer-review

32 Citations (Scopus)

Abstract

To retrospectively evaluate the 12-month effectiveness of the Endeavor zotarolimus-eluting stent (ZES) in diabetic versus non-diabetic patients enrolled in the E-Five Registry.
Original languageEnglish
Pages (from-to)848 - 853
Number of pages6
JournalHeart
Volume96
Issue number11
DOIs
Publication statusPublished - 2010

Cite this